| Product Code: ETC7638368 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Ireland saw a significant shift in pregabalin import shipments, with top exporting countries being China, Netherlands, Switzerland, Metropolitan France, and Italy. The market concentration, as measured by the HHI, increased from moderate to high in 2024, indicating a more consolidated market landscape. Despite a low growth rate from 2023 to 2024, the compound annual growth rate (CAGR) from 2020 to 2024 remained positive at 0.42, suggesting steady expansion over the four-year period. This data highlights the evolving dynamics of the pregabalin market in Ireland and the growing influence of key exporting countries.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Ireland Pregabalin Market Overview | 
| 3.1 Ireland Country Macro Economic Indicators | 
| 3.2 Ireland Pregabalin Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Ireland Pregabalin Market - Industry Life Cycle | 
| 3.4 Ireland Pregabalin Market - Porter's Five Forces | 
| 3.5 Ireland Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.6 Ireland Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F | 
| 3.7 Ireland Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Ireland Pregabalin Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of chronic pain conditions in Ireland | 
| 4.2.2 Growing awareness and acceptance of pregabalin as an effective treatment for neuropathic pain | 
| 4.2.3 Rise in healthcare expenditure and government initiatives to improve access to pain management medications | 
| 4.3 Market Restraints | 
| 4.3.1 Stringent regulatory requirements for prescribing and dispensing pregabalin | 
| 4.3.2 Potential side effects and abuse/misuse concerns associated with pregabalin | 
| 4.3.3 Competition from alternative pain management therapies and generic pregabalin products | 
| 5 Ireland Pregabalin Market Trends | 
| 6 Ireland Pregabalin Market, By Types | 
| 6.1 Ireland Pregabalin Market, By Application | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Ireland Pregabalin Market Revenues & Volume, By Application, 2021- 2031F | 
| 6.1.3 Ireland Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F | 
| 6.1.4 Ireland Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F | 
| 6.1.5 Ireland Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F | 
| 6.1.6 Ireland Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 Ireland Pregabalin Market, By Drug Class | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Ireland Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F | 
| 6.2.3 Ireland Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F | 
| 6.2.4 Ireland Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.3 Ireland Pregabalin Market, By Distribution Channel | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Ireland Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F | 
| 6.3.3 Ireland Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F | 
| 6.3.4 Ireland Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F | 
| 6.3.5 Ireland Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 Ireland Pregabalin Market Import-Export Trade Statistics | 
| 7.1 Ireland Pregabalin Market Export to Major Countries | 
| 7.2 Ireland Pregabalin Market Imports from Major Countries | 
| 8 Ireland Pregabalin Market Key Performance Indicators | 
| 8.1 Number of prescriptions for pregabalin in Ireland | 
| 8.2 Patient adherence and persistence rates for pregabalin treatment | 
| 8.3 Physician and patient satisfaction surveys regarding the efficacy and tolerability of pregabalin | 
| 9 Ireland Pregabalin Market - Opportunity Assessment | 
| 9.1 Ireland Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.2 Ireland Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F | 
| 9.3 Ireland Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Ireland Pregabalin Market - Competitive Landscape | 
| 10.1 Ireland Pregabalin Market Revenue Share, By Companies, 2024 | 
| 10.2 Ireland Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |